Comments
Loading...

Y-mAbs Therapeutics Stock Price, Quotes and Forecasts

YMABNASDAQ
Logo brought to you by Benzinga Data
$4.80
0.306.67%
At close: -
$4.80
0.000.00%
After Hours: 4:24 PM EDT
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Y-mAbs Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:YMAB | Benzinga

Explore Y-mAbs Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for YMAB.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
2
Nov 24
2
Dec 24
1
Jan
2
1
1
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$4.52
Close$4.80
Volume / Avg.238.83K / 429.80K
Day Range$4.40 - $4.82
52 Wk Range4.25 - 17.78
Market Cap$214.99M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
44
Short Interest
11.88%
Days to Cover11.91
About Y-Mabs Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
YMAB
VYGR

FAQ

Q

How do I buy Y-mAbs Therapeutics (YMAB) stock?

A

You can purchase shares of Y-mAbs Therapeutics (NASDAQ:YMAB) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Y-mAbs Therapeutics (YMAB) competitors?

Q

What is the forecast, or price target, for Y-mAbs Therapeutics (YMAB) stock?

A

Y-mAbs Therapeutics has a consensus price target of $18.07.

Q

What is the current price for Y-mAbs Therapeutics (YMAB)?

A

The stock price for Y-mAbs Therapeutics (NASDAQ: YMAB) is $4.8 last updated April 2, 2025 at 4:24 PM EDT.

Q

Does Y-mAbs Therapeutics (YMAB) pay a dividend?

A

There are no upcoming dividends for Y-mAbs Therapeutics.

Q

When is Y-mAbs Therapeutics (NASDAQ:YMAB) reporting earnings?

A

Y-mAbs Therapeutics’s Q1 earnings are confirmed for Tuesday, May 6, 2025.

Q

Is Y-mAbs Therapeutics (YMAB) going to split?

A

There is no upcoming split for Y-mAbs Therapeutics.

Q

What sector and industry does Y-mAbs Therapeutics (YMAB) operate in?

A

Y-mAbs Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch